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Poster Session II 163procedures. The second day of training is the cell infusion day. The
nurse reinforces teaching with the patient and family and assists the
physician with the cell infusion. The third day consists of review of
the infusion procedure, complications review and competency com-
pletion. The clinical nurse specialist or instructor will serve as a re-
source to the nurse during the next transplant assignment.
Currently, more than half the nurses are trained to care for trans-
plant patients. The nurses report satisfaction with the training.
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STANDARDIZING CENTRAL VENOUS LINE CARE IN INPATIENT PEDIAT-
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STREAM INFECTION RATES?
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Central venous catheter related blood stream infections (CRBSI)
increase morbidity and mortality in pediatric hematopoietic stem
cell transplant (HSCT) recipients. There are limited data in the pe-
diatric HSCT population regarding the incidence of CRBSI. Stud-
ies in adult oncology and HSCT patients have reported the average
rate to be 2.5 CRBSI per 1000 patient-days. We hypothesized that
adherence to evidence-based practices shown to reduce CRBSI in
short term central venous lines (CVLs) would also reduce CRBSI
in long term CVLs. We report the preliminary results of standard-
izing CVL care and the resultant effect on the incidence of CRBSI.
A multidisciplinary team reviewed current policies and procedures
for long term CVL care and updated these according to evidence-
based practice derived from CDC and Child Health Corporation
of America. From January – May 2007, ‘‘the education phase’’, inpa-
tient HSCT RNs were in-serviced on correct technique for dressing
changes and for drawing blood from CVLs. Additional practice
changes included the technique used to disinfect the catheter hub
prior to line entry and limiting daily line entries. From February-
May, staff received booster education via face-to-face meetings
and weekly e-mails. From May-September 2007, ‘‘the intervention
phase’’, observations of inpatient nurses were performed by 4 nurse
practitioners and compliance was scored based on set criteria.
CRBSI was defined as a positive blood culture$ 48 hours after ad-
mission treated with antimicrobials. CRBSI rates were assessed per
1000 patient-days. In 2006, prior to this initiative, the average
CRBSI rate in pediatric HSCT patients was 6.07 CRBSI per 1000
patient-days (range 0–8.97). During the education phase, the aver-
age CRBSI rate was 8.15 (2.49–13.22). Improved compliance with
desired practices related to dressing changes (n 5 34) and blood
drawing (n 5 79) is shown below. During the intervention period,
the average CRBSI rate was 0.67 per 1000 patient days (0–3.33). Ed-
ucation alone did not impact CRBSI rates. Only when direct obser-
vations of CVL care were implemented did the rate of CRBSI
significantly decrease. The multidisciplinary team is currently mon-
itoring sustained adherence to practice changes, collecting CRBSI
rates in pediatric HSCT outpatients, developing a plan to increase
patient/family and home care education, and assessing risk factors
for CRBSI.462
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Purpose: A broad range of literature exists detailing the in-
formed-consent process, with much of it evaluating the delivery,
comprehension and long-term recall of information, as well as is-
sues of regulatory significance and compliance. Limited attention,
however, has been paid to the elements beyond information and
regulatory compliance that influence decision-making in cancer re-
search centers. This study examined decision-making in an HSCT
quaternary cancer research center (QCRC)from the patient/family
perspective. One study objective was to describe how individualstreated at a quaternary cancer research center make decisions about
participating in research. a. What/who do patients identify as influ-
ential in forming the decision to participate in research? b. Where/
when do research participants identify themselves as having made
the decision? What are the reasons for the decision? Rationale:
This exploratory project postulated clinical decision making in
a QCRC is a significantly different process than that occurring in
the standard medical setting where medical outcome information
is more abundant, other alternatives exist, and research participants,
in general, are making decisions in locations close to their homes.
Given the medical condition and the often advanced stage of the dis-
ease in such instances, it is difficult to assure that these research par-
ticipation decisions are free of coercion and are voluntarily made.
Methods: This was a descriptive qualitative study enrolling 25
HSCT patients and family members, (N 5 47) who had over
time, 3 semi-structured, audio-taped interviews with investigators:
pre-HSCT (but following decision to participate in research proto-
col for HSCT) and subsequently on days 80 and 360 post-HSCT.
The study began in June 2004 and the last interview was in Decem-
ber 2006. Interviews were transcribed and analyzed using HyperRe-
search software. Findings: Analysis of the data revealed
participants identified distinct characteristics specific to the deci-
sion making processes in a QCRC for a HSCT. The timing of
the decision, the reasoning for the decision, and the influences ex-
erted upon that decision were articulated. Additional findings in-
cluded clarification of general needs for cancer decision making
throughout the illness trajectory. Recommendations will be offered
for improving informed consent process in cancer research settings
in QCRC, secondary or tertiary centers. Funding: NINR National
Institute of Research R21NR00947.463
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Patients receiving hematopoietic stem cell transplantation may
experience considerable reductions in physical activity and deterio-
ration of their performance status. Exercise has been identified as an
effective intervention to improve physical activity and muscle
strength. Little is known, however, regarding the appropriate inten-
sity and timing of an exercise intervention in this population. The
purpose of this study was to determine the feasibility and acceptabil-
ity of a strength training intervention in patients receiving hemato-
poietic stem cell transplantation (HSCT). The convenience sample
(n 5 10) included patients receiving HSCT drawn from an aca-
demic medical center. Design: This study used a prospective, re-
peated measures design. The home-based strength training
intervention was introduced in the hospital and continued for six
weeks following discharge from the hospital. Dependent variables
included physical activity, muscle strength, fatigue, perceived health
status, and quality of life. These variables were measured prior to
admission to the hospital for HSCT, on day 8 following HSCT,
and six weeks following discharge from the hospital. Most subjects
(n 5 7) were able to implement the strength training intervention
using elastic resistance bands. More patients adhered to the exercise
prescription in weeks 5 and 6 compared to weeks 1 and 2. The pa-
tient’s ability to adhere to the exercise prescription required weekly
assessments, particularly in the initial weeks following discharge
from the hospital. Physical activity significantly declined following
the HSCT then improved six weeks following discharge from the
hospital (p\ .05). Hand grip muscle strength significantly declined
six weeks following hospital discharge compared to baseline levels
(p\ .05). The findings suggest that it is feasible to conduct an ex-
ercise intervention in most patients receiving intensive cancer ther-
apy. Subjects required more frequent monitoring of their exercise
prescription due to their changing physical condition. Physical ac-
tivity levels improved following the exercise intervention while
hand grip muscle strength did not. Phase 2 of this study is currently
underway comparing strength training to usual activity on physical
activity, muscle strength, fatigue, health status perceptions, and
quality of life.
